Table 2.
Total | Cycling | Routine | |
N=66 | N=36 | N=30 | |
Mechanical ventilation | |||
Days of invasive mechanical ventilation, median (IQR), days | 8 (5–19) | 8.5 (5–17) | 8 (5–19) |
Days of ETT airway access, median (IQR), days | 7 (5–13) | 7 (5–13) | 8 (5–13) |
Non-invasive mechanical ventilation, n (%) | 9 (13.6) | 6 (16.7) | 3 (10.0) |
Other advanced ventilation, n (%)* | 4 (6.1) | 2 (5.6) | 2 (6.7) |
Other advanced life support | |||
Vasopressor or inotrope infusion, n (%) | 39 (59.1) | 24 (66.7) | 15 (50.0) |
Renal replacement therapy, n (%) | 8 (12.1) | 4 (11.1) | 4 (13.3) |
Infusions | |||
Opiates, n (%) | 44 (66.7) | 26 (72.2) | 18 (60.0) |
Benzodiazepines, n (%) | 24 (36.4) | 14 (38.9) | 10 (33.3) |
Propofol, n (%) | 49 (74.2) | 26 (72.2) | 23 (76.7) |
Neuromuscular blockers, n (%) | 7 (10.6) | 2 (5.6) | 5 (16.7) |
This table summarises ICU exposures received by the Cycling and Routine physical therapy groups.
*Other advanced ventilation includes extracorporeal membrane oxygenation and nitric oxide.
ETT, endotracheal tube; ICU, intensive care unit; IQR, interquartile range.